EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer

Lina Song, Yali Gao, Zhicong Wang, Yufeng Shi

Geburtshilfe und Frauenheilkunde · 01.04.2024 · 84 (04) · 370-377

DOI: 10.1055/a-2275-0717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.04.2024. Verfasst von Lina Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Therapy, Cangzhou Central Hospital, Cangzhou, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is a significant global health burden, and individualized treatment approaches are necessary due to its heterogeneity. Radiotherapy is a common treatment modality; however, the response varies among patients. The identification of reliable biomarkers to predict radiotherapy sensitivity is crucial. A cohort of 189 patients with stage IB2-IVA cervical cancer, treated with radiotherapy alone or concurrent chemoradiotherapy, was included. Serum samples were collected before treatment, and intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) concentrations were determined. Patients were categorized into radiotherapy-sensitive (RS) and radiotherapy-resistant (RR) groups based on treatment response. Clinicopathological characteristics and survival rates were analyzed. The analysis of clinicopathological characteristics showed that age, family history of cervical cancer and post-menopausal status did not significantly differ between RS and RR groups. Tumor size demonstrated a borderline significant association with radiotherapy response, while differentiation degree was significantly associated. Serum ICAM-1 and VCAM-1 concentrations were significantly higher in the RR group compared to the RS group. Combined detection of ICAM-1 and VCAM-1 improved the predictive ability for radiotherapy sensitivity. Higher serum ICAM-1 and VCAM-1 levels were observed in patients with lower tumor differentiation. Five-year overall survival rates differed significantly between patients with high and low ICAM-1 and VCAM-1 levels. Serum ICAM-1 and VCAM-1 levels show potential as predictive biomarkers for radiotherapy sensitivity in cervical cancer.

Schlagwörter

Stichwörter der Autor:innen

cervical cancerintercellular adhesion molecule 1 (ICAM-1)vascular cell adhesion molecule 1 (VCAM-1)

Autor:innen und Institutionen

  • Department of Radiation Therapy, Cangzhou Central Hospital, Cangzhou, China.

Zitieren

APA

Song, L., Gao, Y., Wang, Z., & Shi, Y. (2024). Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer. Geburtshilfe und Frauenheilkunde, 84(04), 370-377. https://doi.org/10.1055/a-2275-0717

Vancouver

Song L, Gao Y, Wang Z, Shi Y. Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer. Geburtshilfe und Frauenheilkunde. 2024;84(04):370-377. doi:10.1055/a-2275-0717

BibTeX
@article{Song2024,
  author = {Song, Lina and Gao, Yali and Wang, Zhicong and Shi, Yufeng},
  title = {Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer},
  journal = {Geburtshilfe und Frauenheilkunde},
  year = {2024},
  volume = {84},
  number = {04},
  pages = {370--377},
  doi = {10.1055/a-2275-0717}
}
Kostenlos starten →